MedPath
HSA Approval

EPLERENONE MEVON FILM-COATED TABLETS 50 MG

SIN16940P

EPLERENONE MEVON FILM-COATED TABLETS 50 MG

EPLERENONE MEVON FILM-COATED TABLETS 50 MG

February 6, 2024

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C03DA04

eplerenone

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

Pharmathen S.A.

Active Ingredients

Eplerenone

50.000 mg

Eplerenone

Documents

Package Inserts

Eplerenone Mevon Tablets PI.pdf

Approved: February 6, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EPLERENONE MEVON FILM-COATED TABLETS 50 MG - HSA Approval | MedPath